Individuals will need to have absolutely recovered within the acute harmful results of all prior anti-most cancers therapy and have to meet the subsequent least duration from prior anti-most cancers directed therapy prior to enrollment. Experimental: Dose expansion_sub-inhabitants 2_higher dose of niraparib MTDs and/or prospect RP2Ds for elimusertib utilized in https://mohamedp887bnx0.bloggazza.com/profile